title: Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum.
abstract: BACKGROUND
  Apical membrane antigen 1 (AMA-1) and merozoite surface protein 1 (MSP1) of Plasmodium falciparum are two leading blood-stage malaria vaccine candidates. A P. falciparum chimeric protein 2.9 (PfCP-2.9) has been constructed as a vaccine candidate, by fusing AMA-1 domain III (AMA-1 (III)) with a C-terminal 19 kDa fragment of MSP1 (MSP1-19) via a 28-mer peptide hinge. PfCP-2.9 was highly immunogenic in animal studies, and antibodies elicited by the PfCP-2.9 highly inhibited parasite growth in vitro. This study focused on locating the distribution of epitopes on PfCP-2.9.
  
  
  METHODS
  A panel of anti-PfCP-2.9 monoclonal antibodies (mAbs) were produced and their properties were examined by Western blot as well as in vitro growth inhibition assay (GIA). In addition, a series of PfCP-2.9 mutants containing single amino acid substitution were produced in Pichia pastoris. Interaction of the mAbs with the PfCP-2.9 mutants was measured by both Western blot and enzyme-linked immunosorbent assay (ELISA).
  
  
  RESULTS
  Twelve mAbs recognizing PfCP-2.9 chimeric protein were produced. Of them, eight mAbs recognized conformational epitopes and six mAbs showed various levels of inhibitory activities on parasite growth in vitro. In addition, seventeen PfCP-2.9 mutants with single amino acid substitution were produced in Pichia pastoris for interaction with mAbs. Reduced binding of an inhibitory mAb (mAb7G), was observed in three mutants including M62 (Phe491-->Ala), M82 (Glu511-->Gln) and M84 (Arg513-->Lys), suggesting that these amino acid substitutions are critical to the epitope corresponding to mAb7G. The binding of two non-inhibitory mAbs (mAbG11.12 and mAbW9.10) was also reduced in the mutants of either M62 or M82. The substitution of Leu31 to Arg resulted in completely abolishing the binding of mAb1E1 (a blocking antibody) to M176 mutant, suggesting that the Leu residue at this position plays a crucial role in the formation of the epitope. In addition, the Asn15 residue may also play an important role in the global folding of PfCP-2.9, as its substitution by Arg lead to reduced binding of most mAbs and abolishing the binding of mAb6G and mAbP5-W12.
  
  
  CONCLUSIONS
  This study provided valuable information on epitopes of PfCP-2.9 vaccine candidate through generation of a panel of mAbs and a series of PfCP-2.9 mutants. The information may prove to be useful for designing more effective malaria vaccines against blood-stage parasites.
authors.affiliation: Department of Pathogenic Biology, Second Military Medical University, 800 Xiang Yin Road, Shanghai 200433, China.
authors.forename: Changling
authors.initials: C
authors.lastname: Li
authors.forename: Rui
authors.initials: R
authors.lastname: Wang
authors.forename: Yuan
authors.initials: Y
authors.lastname: Wu
authors.forename: Dongmei
authors.initials: D
authors.lastname: Zhang
authors.forename: Zhicheng
authors.initials: Z
authors.lastname: He
authors.forename: Weiqing
authors.initials: W
authors.lastname: Pan
mesh_terms: D000595:Amino Acid Sequence; D019943:Amino Acid Substitution / Q000235:genetics; D000818:Animals; D000911:Antibodies, Monoclonal / Q000097:blood / Q000235:genetics / Q000276:immunology*; D015153:Blotting, Western; D004797:Enzyme-Linked Immunosorbent Assay; D018604:Epitope Mapping / Q000379:methods*; D000939:Epitopes; D004912:Erythrocytes / Q000276:immunology; D017780:Malaria Vaccines / Q000097:blood / Q000235:genetics / Q000276:immunology*; D016778:Malaria, Falciparum / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D009154:Mutation; D010843:Pichia / Q000235:genetics / Q000276:immunology; D010963:Plasmodium falciparum / Q000235:genetics / Q000254:growth & development / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000235:genetics / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D000939:Epitopes; D017780:Malaria Vaccines; C535092:PfCP2.9 vaccine; D014614:Vaccines, Synthetic
references.citation: J Biol Chem. 2001 Aug 17;276(33):31311-20
references.pmid: 11399764
references.citation: Infect Immun. 2002 Sep;70(9):5328-31
references.pmid: 12183594
references.citation: Nature. 1975 Aug 7;256(5517):495-7
references.pmid: 1172191
references.citation: Mol Microbiol. 2000 Nov;38(4):706-18
references.pmid: 11115107
references.citation: J Mol Biol. 2007 Mar 9;366(5):1523-37
references.pmid: 17229439
references.citation: Curr Opin Microbiol. 2005 Aug;8(4):422-7
references.pmid: 16019257
references.citation: Infect Immun. 2005 Apr;73(4):2116-22
references.pmid: 15784553
references.citation: Mol Biochem Parasitol. 2005 Nov;144(1):55-67
references.pmid: 16154214
references.citation: PLoS One. 2008 Apr 09;3(4):e1952
references.pmid: 18398475
references.citation: Vaccine. 2007 Mar 1;25(11):2112-9
references.pmid: 17241708
references.citation: PLoS Pathog. 2005 Nov;1(3):241-51
references.pmid: 16322767
references.citation: Biochemistry. 2005 Jan 18;44(2):518-23
references.pmid: 15641776
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12295-300
references.pmid: 14526103
references.citation: J Mol Biol. 2003 May 16;328(5):1091-103
references.pmid: 12729744
references.citation: J Biol Chem. 2003 Jun 27;278(26):23890-8
references.pmid: 12686561
references.citation: Nat Med. 2000 Jan;6(1):91-5
references.pmid: 10613831
references.citation: Vaccine. 2008 Dec 9;26(52):6864-73
references.pmid: 18930094
references.citation: J Immunol. 2008 Dec 15;181(12):8776-83
references.pmid: 19050299
references.citation: Mol Biochem Parasitol. 2004 Sep;137(1):143-9
references.pmid: 15279960
references.citation: J Mol Biol. 1999 May 28;289(1):113-22
references.pmid: 10339410
references.citation: Gene. 1989 Apr 15;77(1):51-9
references.pmid: 2744487
references.citation: Malar J. 2010 Mar 18;9:76
references.pmid: 20236549
references.citation: J Immunol. 2004 May 15;172(10):6167-74
references.pmid: 15128804
references.citation: J Mol Biol. 2002 Sep 27;322(4):741-53
references.pmid: 12270711
references.citation: J Mol Biol. 2001 Apr 13;307(5):1381-94
references.pmid: 11292349
references.citation: Mol Biochem Parasitol. 2004 Nov;138(1):29-36
references.pmid: 15500913
references.citation: J Mol Biol. 1991 Feb 20;217(4):721-9
references.pmid: 2005621